Sponsor pipeline

Mehmet Akce clinical trial pipeline

Get alerts when Mehmet Akce's trials change

2 active trials 1 recruiting 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-03
Primary completion pushed: 2026-07 → 2027-07
Completion pushed: 2027-07 → 2028-07
NCT06728410 A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced… · Phase 2

Active trials by phase

Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT06728410 A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced… Intrahepatic Cholangiocarcinoma Recruiting 2026-09-02
NCT06855225 A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine… Combined Hepatocellular and Cholangiocarcinoma Not Yet Recruiting 2026-09-02

Disease areas by active trials

Cholangiocarcinoma (2)

Get alerts when Mehmet Akce's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free